Data as of 3:59pm ET
| +0.12 / +3.81%|
The 5 analysts offering 12-month price forecasts for OncoGenex Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 14.00 and a low estimate of 4.25. The median estimate represents a +144.65% increase from the last price of 3.27.
The current consensus among 5 polled investment analysts is to Buy stock in OncoGenex Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.